Biomarkers of infection for the differential diagnosis of pleural effusions Source: Eur Respir J 2009; 34: 1383-1389 Year: 2009
The use of pleural fluid C-reactive protein level, as a diagnostic marker for pleural effusions Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience Year: 2009
Diagnostic value of pleural fluid angiopoietin-2 (Ang-2) levels, to differentiate malignant pleural effusions from benign pleural effusions Source: International Congress 2016 – Mesothelioma and malignant pleural disease Year: 2016
Serum albumin and probability of pleural effusion in patients with community-acquired pneumonia Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections Year: 2013
Potential role of total antioxidant status ratio in differential diagnosis of pleural effusion Source: Annual Congress 2013 –Interventional pulmonology and pleural diseases Year: 2013
Diagnostic value of pleural fluid adenosine deaminase level in patient with tuberculous pleurisy Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA) Year: 2016
Diagnostic utility of albumin gradient and fluid to serum albumin ratio in separation of pleural effusion Source: Eur Respir J 2006; 28: Suppl. 50, 579s Year: 2006
Human beta defensin-2 serum levels are lower in complicated infectious pleural effusions Source: Annual Congress 2013 –Interesting research questions Year: 2013
Pleural fluid, serum β-HCG levels and pleural fluid/serum β-HCG ratio for the discrimination of malignant and benign pleural effusions Source: Eur Respir J 2003; 22: Suppl. 45, 60s Year: 2003
Correlation between pleural fluid and serum C-reactive protein in patients with pleural effusion due to different etiologies Source: Virtual Congress 2020 – Interesting clinical problems for the respiratory physician Year: 2020
Serum procalcitonin as a potential biomarker of surgery in parapneumonic pleural effusions Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016
Accuracy of pleural fluid c-reactive protein in differentiating between tuberculous and malignant pleural effusions: a meta-analysis Source: International Congress 2019 – Tuberculosis and comorbidities Year: 2019
Diagnostic values of inflammation biomarkers in pleural effusions (PE) Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors Year: 2015
Pleural fluid pH, LDH, total protein, albumin and glucose levels as a predictor of successful pleurodesis for patient with malignant pleural effusions Source: Eur Respir J 2002; 20: Suppl. 38, 438s Year: 2002
Pleural fluid and plasma D-dimer levels tuberculous pleurisy: the diagnostic value and relation with clinical parameters Source: Annual Congress 2009 - Extrapulmonary tuberculosis and non-tuberculous-mycobacteria (NTM) infections Year: 2009
A new parameter in the separation of exudates from transudates: ratio of pleural fluid albumin to serum albumin Source: Eur Respir J 2005; 26: Suppl. 49, 446s Year: 2005
Expression of YKL-40 and MIP-1a proteins in exudates and transudates: Biomarkers for differential diagnosis of pleural effusions? Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies Year: 2014
The diagnostic value of pleural fluid C-reactive protein level in pleural effusions Source: Eur Respir J 2002; 20: Suppl. 38, 356s Year: 2002
Diagnostic value of ADA total and ADA2 isoenzyme and 2‘deoxyadenosin/ADA ratio in tuberculous pleural effusion in Iran Source: Eur Respir J 2005; 26: Suppl. 49, 687s Year: 2005
Pleural fluid procalcitonin levels in identifying pleural effusions due to infection Source: Annual Congress 2009 - Aetiology and diagnosis of lower respiratory tract infections Year: 2009